Breach of Fiduciary Duty Claims in USA

Breach of fiduciary duty claims in the USA arise when a person entrusted with authority over another';s interests acts in a way that violates that trust. These claims are central to corporate litigation, shareholder disputes, and partnership conflicts across every US jurisdiction. The financial exposure can be severe - remedies range from compensatory damages and disgorgement of profits to injunctive relief and, in egregious cases, punitive damages. This guide covers the legal foundations of fiduciary duty under US law, the elements plaintiffs must prove, the defences available to defendants, procedural considerations, and the strategic choices that shape outcomes for international business clients.

A fiduciary duty is a legal obligation requiring one party - the fiduciary - to act in the best interests of another party - the beneficiary. The concept is deeply embedded in US common law and has been developed extensively through Delaware corporate jurisprudence, which governs a majority of publicly traded and closely held corporations incorporated in that state. Most other states follow broadly similar principles, though the precise contours vary.

In the corporate context, fiduciary duties attach primarily to directors, officers, controlling shareholders, and certain advisers. The two core duties are the duty of care and the duty of loyalty. The duty of care requires fiduciaries to act with the diligence, prudence, and skill that a reasonably careful person would exercise in similar circumstances. The duty of loyalty requires fiduciaries to place the corporation';s interests ahead of their own personal interests, avoiding self-dealing and conflicts of interest.

Delaware courts have also recognised a duty of candour - sometimes called the duty of disclosure - which requires fiduciaries to provide complete and accurate information to shareholders when seeking their approval for a transaction. Some courts treat this as a subset of the duty of loyalty rather than a standalone obligation. In addition, the implied covenant of good faith and fair dealing operates in certain contexts, though Delaware has been careful to limit its application to avoid swallowing the other duties.

Beyond the corporate sphere, fiduciary duties arise in partnerships, limited liability companies, trusts, investment advisory relationships, and attorney-client relationships. The analysis in each context differs, but the core principle - that the fiduciary must subordinate personal interests to those of the beneficiary - remains constant.

To succeed on a breach of fiduciary duty claim in the USA, a plaintiff must establish four elements. Each element carries its own evidentiary and legal complexity, and weakness in any one can defeat an otherwise compelling case.

The first element is the existence of a fiduciary relationship. Courts will not imply a fiduciary relationship from an ordinary commercial contract. The relationship must arise from a position of trust, confidence, or control - such as a director';s relationship to the corporation, a general partner';s relationship to limited partners, or a trustee';s relationship to beneficiaries. A common mistake made by foreign founders unfamiliar with US law is assuming that a close business relationship or a minority shareholding automatically creates fiduciary obligations. It does not.

The second element is a breach of the duty owed. The plaintiff must identify the specific conduct that violated the applicable standard. In a duty of loyalty claim, this typically involves self-dealing transactions, usurpation of corporate opportunities, or undisclosed conflicts of interest. In a duty of care claim, the plaintiff must show that the fiduciary failed to act with appropriate diligence - for example, by approving a transaction without adequate information or deliberation.

The third element is causation. The breach must have caused the harm alleged. Courts apply a "but for" causation standard in most jurisdictions, requiring the plaintiff to show that the loss would not have occurred absent the breach. In complex corporate transactions, establishing causation can be technically demanding and often requires expert testimony on valuation and financial modelling.

The fourth element is damages. The plaintiff must quantify the harm suffered. In fiduciary duty cases, courts may award compensatory damages measured by the loss to the corporation or beneficiary, or they may order disgorgement of profits the fiduciary gained from the breach. In cases involving particularly egregious conduct, some jurisdictions permit punitive damages, though this remedy is not universally available in fiduciary duty litigation.

One of the most strategically significant aspects of US fiduciary duty litigation is the standard of review a court applies to the challenged conduct. The standard determines how much deference the fiduciary receives and, consequently, how difficult it is for the plaintiff to prevail.

The business judgment rule is the default standard in Delaware and most other US jurisdictions. Under this rule, courts presume that directors and officers acted on an informed basis, in good faith, and in the honest belief that the action was in the best interests of the corporation. A plaintiff challenging a board decision under the business judgment rule must rebut this presumption by showing that the directors were not independent, were not adequately informed, or did not act in good faith. This is a high bar, and most challenges under the business judgment rule fail.

The enhanced scrutiny standard applies in specific circumstances, most notably in the context of defensive measures adopted by a board in response to a hostile takeover bid. Under the Unocal doctrine, the board must show that it had reasonable grounds to believe a threat existed and that its response was proportionate to that threat. A similar enhanced scrutiny standard applies under Revlon when a board is overseeing the sale of the company, requiring directors to act reasonably to maximise shareholder value.

The entire fairness standard is the most demanding review and applies when a transaction involves a controlling shareholder on both sides, or when the business judgment rule has been rebutted. Under entire fairness, the defendant must demonstrate both fair dealing - meaning a fair process - and fair price. This is a defendant-unfriendly standard, and cases reviewed under entire fairness are significantly more likely to result in liability. Structuring transactions to avoid entire fairness review - for example, by using a special committee of independent directors or conditioning approval on a majority-of-the-minority shareholder vote - is a central concern in M&A planning.

In practice, founders should consider the standard of review before structuring any related-party transaction. A transaction that might be commercially sensible can become legally vulnerable if the process used to approve it is inadequate.

A critical procedural distinction in US fiduciary duty litigation is whether the claim is derivative or direct. This distinction affects who has standing to sue, who controls the litigation, and who receives any recovery.

A derivative claim is brought by a shareholder on behalf of the corporation. The harm alleged is harm to the corporation itself - for example, a director who diverted a corporate opportunity to a competing business he personally owns. Because the corporation is the real party in interest, any recovery flows to the corporation rather than to the individual shareholder. Before filing a derivative suit, the plaintiff must typically make a demand on the board of directors to take action, or demonstrate that such a demand would be futile because the board is incapable of impartially evaluating the claim.

The demand futility analysis is highly fact-specific. Under Delaware';s Zuckerberg test, courts ask whether a majority of the board faces a substantial likelihood of personal liability, lacks independence from an interested party, or approved the challenged transaction without adequate information. If demand is excused as futile, the plaintiff may proceed without board approval. If demand is required and the board refuses it, the court will evaluate whether the refusal was a valid exercise of business judgment.

A direct claim, by contrast, is brought by a shareholder for harm suffered personally - distinct from harm to the corporation as a whole. For example, a controlling shareholder who uses his position to squeeze out minority shareholders at an unfair price may be liable directly to those shareholders. The distinction between derivative and direct claims is not always obvious, and courts apply a two-part test: whether the alleged harm is to the corporation or to the shareholder individually, and whether the recovery would go to the corporation or to the shareholder.

Many international clients pursuing or defending US fiduciary duty claims underestimate the procedural complexity of the derivative suit mechanism. A common mistake is filing a derivative action without adequately pleading demand futility, which results in dismissal at an early stage. Engaging experienced US corporate litigation counsel before filing is essential.

If you are evaluating whether a fiduciary duty claim is worth pursuing - or whether your company faces exposure - we can help structure the analysis correctly the first time. Contact us at info@vlolawfirm.com.

Defendants in breach of fiduciary duty cases have a range of substantive and procedural defences. Understanding these defences is as important for plaintiffs assessing the strength of their case as it is for defendants preparing their response.

The most powerful substantive defence is the business judgment rule, discussed above. If the defendant can show that the challenged decision was made by disinterested, independent directors who were adequately informed and acted in good faith, the court will not second-guess the outcome even if it proved commercially disastrous.

Exculpation provisions in corporate charters provide another important defence. Delaware law permits corporations to include a provision in their certificate of incorporation that eliminates or limits the personal liability of directors for breaches of the duty of care. Such provisions are common in Delaware corporations and can entirely bar monetary liability for duty of care claims, though they do not protect against duty of loyalty violations, bad faith conduct, or intentional misconduct.

Ratification is a further defence. If a fully informed, disinterested majority of shareholders approves a transaction after disclosure of all material facts, the ratification can cleanse the transaction and restore business judgment review. However, ratification does not cure a transaction that is inherently unfair, and courts scrutinise whether the disclosure was genuinely complete.

The statute of limitations is a procedural defence that can be decisive. Most states impose a three-year limitations period for breach of fiduciary duty claims, though the period varies by jurisdiction and by the nature of the claim. The discovery rule may toll the limitations period where the plaintiff could not reasonably have discovered the breach earlier, but defendants should not assume that delay by the plaintiff will always be fatal to a claim.

Indemnification and advancement of expenses are also relevant. Delaware law and most corporate charters permit corporations to indemnify directors and officers against claims arising from their service, provided they acted in good faith and in a manner they reasonably believed to be in the corporation';s best interests. Advancement of legal expenses during pending litigation is a separate right that can be critical to a director';s ability to mount a defence.

The remedies available in a successful breach of fiduciary duty case are broader than in a standard contract dispute, reflecting the equitable origins of fiduciary law.

Compensatory damages are the baseline remedy. The plaintiff is entitled to recover the actual financial loss caused by the breach. In corporate cases, this typically requires expert testimony on the value of the corporation or the transaction at issue, and on what the value would have been absent the breach. Valuation disputes are often the most contested aspect of fiduciary duty litigation.

Disgorgement is an equitable remedy requiring the fiduciary to surrender any profits gained from the breach, regardless of whether the plaintiff suffered an equivalent loss. This remedy is particularly significant in cases involving self-dealing transactions, usurpation of corporate opportunities, or insider trading. The rationale is that a fiduciary should not profit from a breach of trust, even if the beneficiary was not directly harmed.

Rescission allows a court to unwind a transaction that was the product of a fiduciary breach. This remedy is most relevant in M&A transactions where a controlling shareholder or conflicted board approved a deal on unfair terms. Rescission is not always practical - particularly after a transaction has closed and assets have been integrated - and courts may award rescissory damages as an alternative.

Injunctive relief can be sought to prevent a breach before it occurs or to halt ongoing conduct. In the M&A context, shareholders frequently seek preliminary injunctions to block a transaction pending full disclosure or a fair process. Courts apply a standard balancing test: likelihood of success on the merits, irreparable harm, balance of hardships, and public interest.

Punitive damages are available in some jurisdictions for particularly egregious fiduciary breaches, but they are not universally permitted in corporate fiduciary duty cases. Delaware, for example, does not generally award punitive damages in fiduciary duty litigation. Other states may be more receptive, making the choice of forum a strategic consideration.

A non-obvious requirement is that plaintiffs seeking equitable remedies such as disgorgement or rescission must act promptly. The equitable doctrine of laches can bar relief where the plaintiff delayed unreasonably and the defendant was prejudiced by that delay, even if the formal limitations period has not expired.

Two scenarios illustrate how breach of fiduciary duty claims arise in practice for international business clients.

In the first scenario, a European founder holds a majority stake in a Delaware-incorporated technology company. The company is approached by a strategic acquirer. The founder, who also serves as CEO and a board member, negotiates a deal that provides him with a significant personal benefit - a consulting agreement and accelerated vesting of his equity - that is not shared with minority shareholders. The minority shareholders bring a direct claim alleging that the founder, as a controlling shareholder, breached his duty of loyalty by extracting a non-ratable benefit. Because the transaction involves a controlling shareholder, the court applies entire fairness review. The founder must demonstrate both a fair process - ideally a special committee of independent directors - and a fair price. Without those procedural protections, the claim is likely to survive a motion to dismiss and proceed to expensive discovery.

In the second scenario, a private equity fund based in Asia holds a significant minority stake in a US portfolio company. The fund';s representative on the board learns of a business opportunity - a potential acquisition target - that would be valuable to the portfolio company. Instead of presenting the opportunity to the board, the fund pursues it through a separate vehicle. The portfolio company';s other shareholders bring a derivative claim alleging usurpation of a corporate opportunity. The analysis turns on whether the opportunity was presented to the corporation first, whether the corporation had the financial capacity to pursue it, and whether the board member was acting in his capacity as a director when he learned of it. This type of claim is particularly common in venture-backed and private equity-backed companies where board members represent competing interests.

Both scenarios underscore that fiduciary duty exposure is not limited to public companies. Closely held corporations, joint ventures, and portfolio companies are equally susceptible, and the stakes for international investors can be substantial.

What is the difference between a duty of care breach and a duty of loyalty breach in US corporate law?

A duty of care breach involves a failure to act with sufficient diligence, prudence, or skill - for example, approving a major acquisition without reviewing financial projections or obtaining independent advice. A duty of loyalty breach involves placing personal interests above those of the corporation - for example, approving a transaction in which the director has an undisclosed financial interest. The distinction matters enormously in practice because most Delaware corporations include exculpation provisions that eliminate monetary liability for duty of care breaches but not for duty of loyalty violations. As a result, duty of loyalty claims are far more likely to result in personal liability for directors and officers. Plaintiffs therefore have a strong incentive to characterise conduct as a loyalty breach rather than a care breach.

How long does a breach of fiduciary duty case typically take and what does it cost?

The timeline and cost vary considerably depending on the complexity of the transaction, the number of parties, and the jurisdiction. A straightforward case in a state court may resolve within one to two years; complex Delaware Court of Chancery litigation involving M&A transactions can take three to five years from filing to final judgment. Legal fees for defendants and plaintiffs in significant corporate fiduciary duty cases frequently reach the mid-to-high six figures, and in major M&A disputes they can run into the millions. Discovery - particularly electronic discovery of board communications and financial records - is often the most time-consuming and expensive phase. Early case assessment, including a realistic evaluation of the standard of review likely to apply, is essential to managing costs and setting expectations.

Can fiduciary duty claims be resolved through arbitration or mediation rather than court litigation?

Increasingly, yes. Many corporate charters and shareholder agreements include arbitration clauses that require fiduciary duty disputes to be resolved through private arbitration rather than in court. Delaware has specifically authorised arbitration of intra-entity disputes for non-public companies. Arbitration can offer advantages including confidentiality, speed, and the ability to select arbitrators with corporate law expertise. Mediation is also widely used as a settlement mechanism, particularly in derivative suits where the parties have an ongoing relationship. However, arbitration clauses in corporate charters for public companies remain controversial, and their enforceability in the shareholder context is not universally settled. International clients should review their corporate documents carefully to understand the dispute resolution mechanism that applies to their specific situation.

Breach of fiduciary duty claims in the USA represent some of the most complex and high-stakes litigation in corporate law. The interplay between the standard of review, the derivative versus direct distinction, and the available remedies creates a landscape where procedural choices are as consequential as substantive ones. International founders, investors, and board members operating in the US market need a clear understanding of these dynamics before a dispute arises - not after.

VLO Law Firms advises international clients on corporate matters, including breach of fiduciary duty claims, in the USA. We can assist with pre-transaction structuring to reduce fiduciary exposure, assessment of existing claims and defences, and representation in corporate litigation and arbitration proceedings. To request a consultation, contact: info@vlolawfirm.com